Welcome to LookChem.com Sign In|Join Free

CAS

  • or

62-67-9

Post Buying Request

62-67-9 Suppliers

Recommended suppliersmore

This product is a nationally controlled contraband, and the Lookchem platform doesn't provide relevant sales information.

62-67-9 Usage

Uses

Biochemical research tool for studying the mechanism of narcotic action; also as an antidote for acute morphine poisoning.

Definition

The allyl (–CH2–CH=CH2) derivative of morphine. It is able to “antagonize” or neutralize most of the effects of narcotic drugs (morphine, codeine) but not those of other types of depressants.

Check Digit Verification of cas no

The CAS Registry Mumber 62-67-9 includes 5 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 2 digits, 6 and 2 respectively; the second part has 2 digits, 6 and 7 respectively.
Calculate Digit Verification of CAS Registry Number 62-67:
(4*6)+(3*2)+(2*6)+(1*7)=49
49 % 10 = 9
So 62-67-9 is a valid CAS Registry Number.
InChI:InChI=1/C19H21NO3/c1-2-8-20-9-7-19-12-4-6-15(22)18(19)23-17-14(21)5-3-11(16(17)19)10-13(12)20/h2-6,12-13,15,18,21-22H,1,7-10H2/t12-,13+,15-,18-,19-/m0/s1

62-67-9SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 17, 2017

Revision Date: Aug 17, 2017

1.Identification

1.1 GHS Product identifier

Product name (4R,4aR,7S,7aR,12bS)-3-prop-2-enyl-2,4,4a,7,7a,13-hexahydro-1H-4,12-methanobenzofuro[3,2-e]isoquinoline-7,9-diol

1.2 Other means of identification

Product number -
Other names Anarcon

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:62-67-9 SDS

62-67-9Relevant articles and documents

Combination of selected opioids with muscarine antagonists for treating urinary incontinence

-

, (2008/06/13)

Active compound combinations of compounds of group A, particularly opioids, and compounds of group B, particularly anti-muscarine agents and other substances suitable for treatment of an increased urge to urinate or urinary incontinence. Related pharmaceutical formulations and methods of treatment of an increased urge to urinate or urinary incontinence are also provided.